摘要
目的:探讨在胸外科手术中舒芬太尼复合丙泊酚静脉麻醉的临床麻醉效果。方法:选择胸外科择期手术患者60例,ASA I或II级,分为观察组(舒芬太尼复合丙泊酚)及对照组(芬太尼复合丙泊酚)进行静脉全麻手术,观察两组患者在麻醉诱导前(T0)、诱导后(T1)、气管插管时(T2)、手术开始时(T3)、切皮后5 min(T4)和术毕(T5)HR、BP的变化,并记录患者的自主呼吸恢复时间、苏醒时间、拔管时间、定向力恢复时间以及对术后患者进行视觉模拟法疼痛(VAS)评分。结果:与对照组相比,发现观察组麻醉及手术过程中血液动力学更加稳定,自主呼吸时间、苏醒时间、拔管时间、定向力恢复时间均缩短,有统计学差异(P<0.05),且观察组的术后2.5 h内的疼痛感明显下降。结论:舒芬太尼在胸外科手术中的麻醉效果优于芬太尼,更值得推广应用于临床麻醉中。
Objective： To investigate the clinical anesthetic effect of doses of sufentanil with propofol for intravenous anesthesia in thoracic surgery. Method： 60 thoracic surgery patients, ASA I or II, were random- ly divided into observation group as doses of sufentanil with propofol and control group as doses of fentanyl with propofol for intravenous anesthesia, then index of HR and BP were recorded at the time of To , T1 , T2, T3 , T4 and T5, and the patient＇s breathing recovery time, recovery time, extubation time, orientation recov- ery time were recorded and postoperative pain was scored by VAS. Result： Compared with the control group, hemodynamics in the observation group was more stable during the anesthesia and surgery, breathing recovery time, recovery time, extubation time, orientation recovery time were shortened with significant difference （ P〈0.05 ）, and postoperative pain 2.5 hours after the surgery was decreased significantly. Con- clusion： The anesthetic effect of sufentanil is superior to fentanyl in thoracic surgery, which is much more worthy of promotion and utilized in clinical anesthesia.
出处
《河北医学》
CAS
2012年第12期1676-1679,共4页
Hebei Medicine
